Security Snapshot

CervoMed Inc. - Common Stock, $0.001 par value (CRVO) Institutional Ownership

CUSIP: 15713L109

13F Institutional Holders and Ownership History from Q3 2023 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

37

Shares (Excl. Options)

1,747,147

Price

$3.10

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock, $0.001 par value
Symbol
CRVO on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
1,747,147
Latest holder snapshot 5 signals
Total 13F value
$5,416,592
Portfolio coverage rank
0%
Share change
-22,421
Value change
-$331,311
Number of holders
37
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
16,714,197
SEC-reported price per share
$2.66
Insider filing price
$2.66
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • CRVO - CervoMed Inc. - Common Stock, $0.001 par value is tracked under CUSIP 15713L109.
  • 37 institutions reported positions in Q2 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 35 to 37 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $6,972,142 to $5,416,592.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 37 institutions filings for Q2 2026.

Open SEC evidence

Security key

15713L109

Latest holder period

Q2 2026

13F holders

37

13D/G owners

6

CIK / CUSIP context first

Open Q2 2026 holders CRVO full holder history CervoMed Inc. SEC filings CervoMed Inc. company facts CervoMed Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
CRVO
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BOGER JOSHUA S 20% $8,309,619 2,204,143 BOGER JOSHUA S 11 Jun 2026
ARMISTICE CAPITAL, LLC 9.5% $5,686,521 1,592,863 Armistice Capital, LLC 30 Jun 2026
RA CAPITAL MANAGEMENT, L.P. 8.6% -13% $4,520,131 +$853,965 1,266,143 +23% RA Capital Management, L.P. 30 Jun 2026
Woodline Partners LP 5.1% $2,459,684 688,987 Woodline Partners LP 30 Jun 2026
AWM Investment Company, Inc. 4.2% -57% $1,596,350 -$1,804,658 405,165 -53% AWM Investment Company, Inc. 31 Mar 2026
MORGAN STANLEY 0.1% -99% $38,905 -$2,254,277 12,550 -98% Morgan Stanley 30 Jun 2026

As of 30 Jun 2026, 37 institutional investors reported holding 1,747,147 shares of CervoMed Inc. - Common Stock, $0.001 par value (CRVO). This represents 10% of the company’s total 16,714,197 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
10%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Woodline Partners LP 4.1% 688,987 0.01% $2,135,859
VANGUARD CAPITAL MANAGEMENT LLC 1.9% 316,202 0% 0% $980,226
SABBY MANAGEMENT, LLC 1.5% 248,880 6.4% $771,528
GEODE CAPITAL MANAGEMENT, LLC 0.4% 66,923 -10% 0% $207,520
BlackRock, Inc. 0.32% 53,845 +4.2% 0% $166,920
Byrne Asset Management LLC 0.31% 51,250 +249% 0.09% $158,875
CITIZENS FINANCIAL GROUP INC/RI 0.22% 37,477 0% 0% $116,179
VANGUARD FIDUCIARY TRUST CO 0.22% 36,151 0% 0% $112,068
JANE STREET GROUP, LLC 0.19% 32,231 +77% 0% $99,916
THOMPSON DAVIS & CO., INC. 0.18% 29,750 +198% 0.06% $92,225
Savvy Advisors, Inc. 0.16% 25,922 0% 0% $80,358
Virtu Financial LLC 0.14% 24,093 0% $75,000
STATE STREET CORP 0.12% 20,527 0% 0% $63,634
Cetera Investment Advisers 0.12% 19,622 -28% 0% $60,828
Summit Financial, LLC 0.11% 18,140 0% $56,234
Russell Investments Group, Ltd. 0.09% 15,363 -4.5% 0% $47,625
NORTHERN TRUST CORP 0.08% 13,318 -56% 0% $41,286
MORGAN STANLEY 0.08% 12,699 -98% 0% $39,367
HighTower Advisors, LLC 0.07% 11,919 +5.8% 0% $36,949
FMR LLC 0.06% 10,538 -4.5% 0% $32,668
NFSG Corp 0.02% 3,000 0% 0% $9,300
Vanguard Global Advisers, LLC 0.02% 2,597 0% 0% $8,051
Tower Research Capital LLC (TRC) 0.01% 2,173 -0.23% 0% $6,736
Federation des caisses Desjardins du Quebec 0.01% 1,700 0% 0% $5,270
HOEY INVESTMENTS, INC 0.01% 1,080 0% 0% $3,348

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
12
Latest
Q2 2026
Rows shown
1-12 of 12
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 1,747,147 $5,416,592 -$331,311 $3.10 37
2026 Q1 1,769,590 $6,972,142 -$5,532,974 $3.94 35
2025 Q4 2,203,903 $17,410,591 +$558,220 $7.90 48
2025 Q3 2,132,491 $17,251,242 +$167,312 $8.09 44
2025 Q2 2,173,154 $13,657,601 -$929,086 $6.28 42
2025 Q1 2,283,166 $20,892,111 +$8,828,449 $9.15 46
2024 Q4 1,485,110 $3,460,093 -$33,750,758 $2.34 42
2024 Q3 3,505,695 $51,185,917 +$596,925 $14.60 48
2024 Q2 3,446,957 $59,012,261 +$15,847,476 $17.12 38
2024 Q1 2,514,408 $58,586,040 +$50,991,141 $23.30 20
2023 Q4 326,440 $2,481,528 -$46,092 $7.63 12
2023 Q3 363,667 $1,681,783 +$1,681,783 $4.62 12
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .